Transpire Bio

Transpire Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route. The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets. Our purpose at Transpire Bio is framed by two core elements: Access and Innovation. For common diseases where adequate therapies exist, we seek to expand access to these complex inhaled medicines globally by developing and commercializing lower-cost generic alternatives. For diseases with few treatment options, we seek to innovate by harnessing existing known mechanisms of action, and dramatically improve the risk-benefit profile of selected molecules by developing these as inhaled therapeutics. Our understanding of the complexities of inhaled drug-device products will allow us to advance these therapies and improve the health of people around the globe.
Looking for a particular Transpire Bio employee's phone or email?

Transpire Bio Questions

News

Transpire Bio Granted Orphan Drug Designation by the U.S. FDA For Two Rare Diseases - GlobeNewswire

Transpire Bio Granted Orphan Drug Designation by the U.S. FDA For Two Rare Diseases GlobeNewswire

Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA - GlobeNewswire

Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA GlobeNewswire

Transpire Bio Announces Progress in Clinical Development with Initiation of a New Human Subject Study for Asthma and COPD Inhaled Drug Program - Yahoo Finance

Transpire Bio Announces Progress in Clinical Development with Initiation of a New Human Subject Study for Asthma and COPD Inhaled Drug Program Yahoo Finance

Transpire Bio Enters into Exclusive License Agreement with - GlobeNewswire

Transpire Bio Enters into Exclusive License Agreement with GlobeNewswire

Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program - Yahoo Finance

Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program Yahoo Finance

Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility - PR Newswire

Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility PR Newswire

Transpire Bio Announces R&D and Manufacturing Expansion - GlobeNewswire

Transpire Bio Announces R&D and Manufacturing Expansion GlobeNewswire

Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program - Yahoo Finance

Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program Yahoo Finance

Top Transpire Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant